Description:
Urgent care centers (UCCs) are a vital and growing segment of the U.S. healthcare system, with around 10,000 locations nationwide. They offer walk-in care, a broad range of services, extended hours, and minimal wait times. Kalorama Information’s report, The U.S. Market for Urgent Care Centers (Including COVID-19, POC Tests, Vaccines and Other Sales), 2nd Edition, provides an in-depth analysis of this dynamic market, examining current trends, challenges, and opportunities for growth, especially in light of the COVID-19 pandemic.
Key Features of the Report:
This comprehensive report delivers essential data and insights for marketers and business planners, including:
- Urgent Care Services Overview: Analysis of the range of services provided by UCCs, from non-emergency acute care to specialized procedures.
- Market Size and Projections: Detailed market sizing and revenue projections segmented by reason for visit, forecasted to 2025.
- COVID-19 Impact: Examination of the effects of COVID-19 on urgent care centers, including test revenues and vaccine distribution.
- Current Trends: Insights into healthcare and insurance trends, competition, and market saturation.
- Key Metrics: Data on the number of locations, revenue per patient, startup costs, staffing, and ownership structures.
- Competitive Landscape: Profiles of major players, including market share and competitive strategies.
Market Insights:
- Growth and Challenges: While the urgent care market is expanding, there are trends that may limit growth. The report explores both the positive and negative impacts of these trends.
- Cost Savings Potential: Urgent care centers offer an affordable alternative to emergency room visits, with significant potential for cost savings. Transitioning non-emergency cases from ERs to UCCs could save up to $18.5 billion annually.
- Supplier Opportunities: UCCs represent a substantial market for pharmaceutical and IVD companies, offering opportunities for sales of point-of-care tests, immunoassays, clinical chemistry, imaging equipment, and vaccines.
Detailed Analysis:
- COVID-19: Impact on urgent care, including test revenues and vaccination efforts.
- Market Size by Visit Type: Detailed segmentation and revenue forecasts by type of visit.
- Supplier Sales: Analysis of sales opportunities for suppliers to UCCs.
- Competition: Examination of competition from new healthcare venues and the impact on UCCs.
- Demographics: Trends in urgent care utilization among seniors and other demographics.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: Respiratory Sales to U.S. Urgent Care Centers, by Segment, 2020-2025 ($ millions)
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Flu Revenue (POC) | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million |
| Strep (POC) | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million |
| RSV and Other (POC) | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million |
| COVID-19 (POC & Send Out) | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million |
Source: Kalorama Information
